Nuo Therapeutics, Inc.

AURX

Nuo Therapeutics, Inc.

AURX

Insider Sentiment (TTM):

Last Purchase:2025-07-30Last Sale:2025-11-28Shares Purchased (TTM):0Shares Sold (TTM):200,000

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,700Shares Outstanding:48,285,303Institutional Ownership Pct.:0.01%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets Current
Cash And Cash Equivalents At Carrying Value	0	0	1	1	0	0	0	1	0	0	1	1
Restricted Cash Current	-	-	-	-	-	-	-	-	-	-	0	0
Accounts Receivable Net Current	1	1	1	1	0	0	0	0	0	0	0	0
Inventory Net	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	2	2	1	1	1	1	1	1	1	1	2	1
Property Plant And Equipment Net	1	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Assets	3	2	2	2	1	1	1	2	1	1	2	2
Liabilities Current
Accounts Payable Current	1	0	0	0	0	1	0	0	0	0	0	0
Accrued Liabilities Current	1	1	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Current	0	0	0	0	0	0	0	-	-	-	-	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	2	1	1	1	1	1	1	1	1	1	1	1
Deferred Revenue Noncurrent	1	1	1	1	1	-	0	-	-	-	-	-
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	4	3	3	2	2	1	1	1	1	1	1	1
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	34	34	34	34	33	33	33	33	32	31	31	30
Retained Earnings Accumulated Deficit	-36	-35	-35	-34	-34	-33	-32	-32	-31	-31	-30	-29
Stockholders Equity	-2	-1	-1	-0	-1	-0	1	1	1	0	1	1
Liabilities And Stockholders Equity	3	2	2	2	1	1	1	2	1	1	2	2
Common Stock Par Or Stated Value Per Share	0	-	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	48	48	48	48	47	47	47	47	45	44	44	42
Shares Outstanding	48	48	48	48	47	47	47	47	45	44	44	42

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-14.07%	-25.19%	-25.93%	-	-	-	-	-	-	-	-	-
2025	-2.70%	-5.78%	-2.64%	2.35%	17.65%	63.29%	-3.11%	-4.44%	-15.56%	-9.72%	-23.12%	-37.17%
2024	0.00%	-57.48%	-57.33%	64.20%	31.38%	69.81%	83.71%	84.37%	76.14%	25.00%	29.08%	25.00%
2023	-	-	-	-	-	-	4.55%	22.33%	9.14%	0.00%	-6.25%	-60.14%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.28	1.11	1.06	1.16	0.85	0.47	1.45	1.88	1.70	1.29	2.32	1.84
Quick Ratio	1.04	0.83	0.85	0.93	0.64	0.26	0.92	1.42	1.13	0.78	1.75	1.27
Working Capital	439.43K	151.00K	73.60K	206.17K	-145.68K	-679.37K	263.10K	628.73K	484.18K	219.81K	888.92K	573.20K
Leverage & Debt
Debt to Equity	-2.71	-2.41	-2.93	-5.59	-2.65	-6.38	1.32	0.93	1.37	2.73	0.81	1.20
Interest Coverage TTM	-5.96	-12.49	-640.69	-786.32	-713.56	-821.12	-1,288.85	-870.42	-856.79	-986.08	-1,001.98	-1,172.68
Debt Ratio	1.58	1.71	1.52	1.22	1.61	1.19	0.57	0.48	0.58	0.73	0.45	0.55
Efficiency & Turnover
Asset Turnover TTM	2.61	2.67	2.18	1.43	1.40	1.35	0.89	0.70	0.73	0.45	0.25	0.18
Days Sales Outstanding TTM	52.22	50.81	44.61	68.59	58.52	57.21	66.70	87.88	89.86	84.92	102.87	98.96
Receivables Turnover TTM	6.99	7.18	8.18	5.32	6.24	6.38	5.47	4.15	4.06	4.30	3.55	3.69
Per Share Metrics
Free Cash Flow Per Share TTM	-0.05	-0.04	-0.02	-0.02	-0.02	-0.04	-0.05	-0.06	-0.06	-0.07	-0.08	-0.08
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	64.11%	65.46%	66.94%	70.38%	76.04%	76.89%	77.82%	77.92%	79.48%	78.74%	79.28%	79.93%
Operating Profit Margin TTM	-33.32%	-53.69%	-75.95%	-98.28%	-133.50%	-154.41%	-180.04%	-212.51%	-261.80%	-386.49%	-520.65%	-716.64%
Net Profit Margin TTM	-38.70%	-57.72%	-75.82%	-93.06%	-126.67%	-146.20%	-170.21%	-212.47%	-261.78%	-386.76%	-521.17%	-716.32%
Growth Metrics
Net Revenue Growth (1Y)	166.61%	155.81%	142.72%	123.72%	89.62%	106.52%	124.34%	140.43%	252.84%	351.11%	442.12%	1,169.31%
Net Income Growth (1Y)	-18.55%	1.00%	8.11%	-2.01%	-8.25%	-21.93%	-26.73%	-28.68%	-25.20%	-17.19%	-0.01%	12.49%
EPS Growth (1Y)	-21.21%	-2.08%	3.80%	-5.98%	-12.49%	-26.23%	-32.13%	-34.11%	-29.99%	-21.76%	-4.94%	9.80%
Valuation Metrics
P/E TTM	-24.29	-29.36	-37.10	-39.90	-28.43	-23.79	-27.37	-10.71	-6.26	-13.17	-7.30	-7.27
P/B TTM	-31.84	-50.59	-97.44	-231.12	-85.18	-263.66	123.79	29.84	28.17	119.41	22.27	34.79
P/S TTM	9.40	16.95	28.13	37.14	36.01	34.79	46.58	22.76	16.39	50.92	38.03	52.08
Market Cap	48.89M	70.01M	93.21M	96.98M	70.23M	56.18M	63.59M	26.57M	16.86M	39.82M	23.14M	25.29M
Enterprise Value	48.44M	69.75M	92.71M	96.47M	69.92M	56.12M	63.31M	25.88M	16.39M	39.45M	22.21M	24.65M
Calculated Values
Free Cash Flow TTM	-2.45M	-1.70M	-1.14M	-1.16M	-1.10M	-2.05M	-2.39M	-2.57M	-2.73M	-2.94M	-3.18M	-3.33M
Net Debt	-449.33K	-263.83K	-500.00K	-514.80K	-316.35K	-55.66K	-283.71K	-683.84K	-473.04K	-366.23K	-928.68K	-637.59K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-28Sale

Owner: Jorden, David Emerson

Title: CEO/CFO

Shares: 200,000

Price/Share: $1.50

Value: $300,000.00

Shares Owned: 1,946,755

Relationship: Director,Officer

Ownership: Direct

2025-07-30Purchase

Owner: Sheedy, Charles E

Title: -

Shares: 133,333

Price/Share: $1.50

Value: $199,999.50

Shares Owned: 11,570,833

Relationship: TenPercentOwner

Ownership: Direct

2024-09-18Purchase

Owner: Sheedy, Charles E

Title: -

Shares: 125,000

Price/Share: $0.75

Value: $93,750.00

Shares Owned: 11,437,500

Relationship: TenPercentOwner

Ownership: Direct

2024-05-20Purchase

Owner: Sheedy, Charles E

Title: -

Shares: 100,000

Price/Share: $0.75

Value: $75,000.00

Shares Owned: 11,312,500

Relationship: TenPercentOwner

Ownership: Direct

2023-12-19Purchase

Owner: Sheedy, Charles E

Title: -

Shares: 150,000

Price/Share: $0.50

Value: $75,000.00

Shares Owned: 11,212,500

Relationship: TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-28	Jorden, David Emerson	Director,Officer	CEO/CFO	Direct	Sale	200,000	1.50	$300,000.00	1,946,755	4
2025-07-30	Sheedy, Charles E	TenPercentOwner	-	Direct	Purchase	133,333	1.50	$199,999.50	11,570,833	4
2024-09-18	Sheedy, Charles E	TenPercentOwner	-	Direct	Purchase	125,000	0.75	$93,750.00	11,437,500	4
2024-05-20	Sheedy, Charles E	TenPercentOwner	-	Direct	Purchase	100,000	0.75	$75,000.00	11,312,500	4
2023-12-19	Sheedy, Charles E	TenPercentOwner	-	Direct	Purchase	150,000	0.50	$75,000.00	11,212,500	4
2023-08-01	Sheedy, Charles E	TenPercentOwner	-	Direct	Purchase	62,500	2.00	$125,000.00	11,062,500	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

0.01%

Inst. Shares: 4,700

Shares Outstanding: 48,285,303

2025-12-31

0.01%

Inst. Shares: 4,700

Shares Outstanding: 47,312,727

2025-09-30

0.01%

Inst. Shares: 4,700

Shares Outstanding: 47,539,384

2025-06-30

0.01%

Inst. Shares: 4,700

Shares Outstanding: 46,823,111

2025-03-31

0.01%

Inst. Shares: 4,700

Shares Outstanding: 46,816,114

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,700	48,285,303	0.01%
2025-12-31	4,700	47,312,727	0.01%
2025-09-30	4,700	47,539,384	0.01%
2025-06-30	4,700	46,823,111	0.01%
2025-03-31	4,700	46,816,114	0.01%
2024-12-31	4,700	45,424,437	0.01%
2024-09-30	4,700	45,613,912	0.01%
2024-06-30	4,700	44,657,742	0.01%
2024-03-31	4,700	44,241,516	0.01%
2023-12-31	4,700	42,077,811	0.01%
2023-09-30	4,700	42,142,141	0.01%
2023-06-30	4,700	41,799,016	0.01%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Nuo Therapeutics, Inc. (AURX) — SEC Financial Statements & Analysis

Nuo Therapeutics, Inc. (AURX) is a surgical & medical instruments & apparatus company, incorporated in DE. Nuo Therapeutics, Inc. trades on OTC as: AURX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Nuo Therapeutics, Inc. reported a 166.61% year-over-year revenue growth, a Gross Profit Margin of 64.11% (TTM), a Debt-to-Equity ratio of -2.71x, a Price-to-Sales (P/S) ratio of 9.40x (TTM), a Price-to-Book (P/B) ratio of -31.84x (TTM), at a market cap of $48.89M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 166.61%
Gross Profit Margin TTM: 64.11%
Debt To Equity: -2.71x
P/S TTM: 9.40x
P/B TTM: -31.84x
Market Cap: $48.89M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Nuo Therapeutics, Inc. in?

Nuo Therapeutics, Inc. (AURX) operates in the Surgical & Medical Instruments & Apparatus industry.

What is AURX's market cap?

Nuo Therapeutics, Inc. (AURX) has a market capitalization of $48.89M as of 2026-06-30.

What exchange does AURX trade on?

Nuo Therapeutics, Inc. (AURX) trades on the OTC.

Where is Nuo Therapeutics, Inc. incorporated?

Nuo Therapeutics, Inc. is incorporated in DE.